Clinical Trial Update: Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 pivotal efficacy and safety trial of FP187 for moderate to severe plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• FP187

Snippet

Sponsor: Forward-Pharma GmbH | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED